EQUITY RESEARCH MEMO

PLD Pharma Services

Generated 5/10/2026

Executive Summary

Conviction (model self-assessment)65/100

PLD Pharma Services, operating as Avéma Pharma Solutions, is a US-based CDMO founded in 2004 that specializes in the development, manufacturing, and packaging of oral solid and liquid dose drugs, with a growing focus on medicated gummies. Leveraging over 35 years of industry expertise, the company offers end-to-end services from R&D to commercial-scale production for small molecule APIs. Its niche in emerging drug delivery systems, particularly medicated gummies, positions it to capture demand from pharmaceutical companies seeking patient-friendly alternatives to traditional oral dosage forms. With a strong presence in the US market and a comprehensive service portfolio, PLD Pharma Services is well-suited to support both early-stage and established drug developers in bringing innovative therapies to market.

Upcoming Catalysts (preview)

  • Q4 2026Major contract win for medicated gummy manufacturing65% success
  • Q2 2026Capacity expansion announcement for gummy production line75% success
  • Q3 2026Partnership with a large pharma for novel oral solid formulation60% success
Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)